Old Web
English
Sign In
Acemap
>
Paper
>
Efficacy and Safety of Loncastuximab Tesirine (ADCT-402) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Efficacy and Safety of Loncastuximab Tesirine (ADCT-402) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
2020
Paolo F. Caimi
Weiyun Z. Ai
Juan Pablo Alderuccio
Kirit M. Ardeshna
Mehdi Hamadani
Brian T. Hess
Brad S. Kahl
John Radford
Melhem Solh
Anastasios Stathis
Pier Luigi Zinzani
Jay Feingold
David Ungar
Yajuan Qin
Shui He
Carmelo Carlo-Stella
Keywords:
Cancer research
Medicine
Diffuse large B-cell lymphoma
relapsed refractory
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
6
Citations
NaN
KQI
[]